FREE Register Now

FREE Registration (First-come, First-served basis)

The Evolution of Precision Medicine- Entering the Era of Muliti-omics

A Talk by John L. Marshall
Chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital, Washington DC, USA

Register to watch this content

By submitting you agree to the Terms & Privacy Policy
Watch this content now

About this talk

John L. Marshall, MD Director, The Ruesch Center for the Cure of GI Cancers Frederick P. Smith Endowed Chair Chief, Hematology and Oncology Lombardi Comprehensive Cancer Center Georgetown University Medical Center

Over the last decade, we have seen a dramatic change in our understanding of cancer biology. As a result, we are increasingly relying on precision medicine to drive new therapeutics and have seen significant improvements in cancer outcomes. Accompanying this dramatic shift are significant changes in practice patterns involving molecular testing and the economic impact on our cancer healthcare systems. The last decade began with a standard of care of occasional single genetic tests being done in specific clinical scenarios. We ended the decade with an increasing standard for broad molecular testing in a high percentage of our patients with metastatic disease. Looking toward the decade ahead, we not only expand our use of broad molecular testing but we will shift towards multi-omic testing requiring the application of artificial intelligence to assist in our decision making.

Categories covered by this talk

Have you got yours yet?

Our All-Access Passes are a must if you want to get the most out of this event.

Check them out

Proudly supported by

Want to sponsor this event? Contact Us.

Loading content...

Loading content...